37 research outputs found
Enhanced Photon Emission of Chemiluminescent Luminophore for Ultra-Fast and Semi-Automatic Immunoassay toward Single Molecule Detection
Optical single molecule detection is normally achieved
via amplifying
the total emission of photons of luminophores and is strongly anticipated
to extend the commercialized application of chemiluminescence (CL).
To overcome the limited CL photons of molecule luminophores, herein,
a nanocrystal (NC) luminophore self-amplified strategy is proposed
to repetitively excite CL luminophores for amplifying the total CL
photons per luminophore, which can be exploited to perform CL immunoassays
(CLIAs) toward single molecule detection via employing KMnO4 as the CL triggering agent and the dual-stabilizer-capped CdTe NCs
as the CL luminophore. KMnO4 can oxidize the S element
from each stabilizer of mercaptopropionic acid (MPA) and release enough
energy to excite the CdTe core for flash CL. The substantial MPA around
each CdTe core enables every CdTe luminophore to be repetitively excited
and give off amplified total CL photons in a self-enhanced way. The
CL of CdTe NCs/KMnO4 can release all photons rapidly, and
the collection of all these photons can be utilized to determine the
model analyte of thyroid-stimulating hormone antigen (TSH) with a
limit of detection of 5 ag/mL (S/N = 3), which is corresponding to
about 2–4 TSH molecules in a 20 μL sample. The whole
immunologic operating process can be terminated within 6 min. This
strategy of repetitively breaking the CL reaction involving chemical
bonds within one luminophore is promising for semi-automatic as well
as fully automatic single molecule detection and extends the commercialized
application of CL immunodiagnosis
Dichroic Mirror-Assisted Electrochemiluminescent Assay for Simultaneously Detecting Wild-type and Mutant p53 with Photomultiplier Tubes
The
electrochemical-dependent and unstable intensity of electrochemiluminescence
(ECL) makes it difficult to identify ECL in a waveband-resolved way
on photomultiplier tube (PMT)-based traditional ECL analyzers. Herein,
a dual-color ECL strategy is proposed by transferring ECL to two PMTs
in a waveband-resolved way via dichroic mirror, simultaneously detecting
wild-type p53 (WTp53) in near-infrared wavebands with CdTe (λ<sub>max</sub> = 782 nm) nanocrystals as tag and mutant p53 (MUp53) in
eye-visible wavebands with CdSe (λ<sub>max</sub> = 554 nm) nanocrystals
as tag. The two targets can be color-selectively determined from 10
fM to 100 pM with a limit of detection at 5 fM for MUp53 and from
50 fM to 100 pM with a limit of detection at 10 fM for WTp53, respectively.
The dichroic mirror-involved ECL setup is easy to assemble for popularization,
which would not only eventually enable PMT-based multiple-color ECL
analysis but also make it is possible to directly determine the changed
level of tumor suppressors for cancer diagnosis and therapeutic evaluation
via one-pot ECL assay
Ultrasensitive Immunoassay Based on Anodic Near-Infrared Electrochemiluminescence from Dual-Stabilizer-Capped CdTe Nanocrystals
A sandwich-typed near-infrared (NIR) electrochemiluminescence
(ECL)
immunoassay was developed with dual-stabilizer-capped CdTe nanocrystals
(NCs) as ECL labels and α fetoprotein antigen (AFP) as model
protein. The dual-stabilizer-capped NIR CdTe NCs were promising ECL
labels because of their NIR ECL emission of 800 nm, low anodic ECL
potential of +0.85 V, and high biocompatibity, which can facilitate
interference-free and highly sensitive ECL bioassays. Upon the immunorecognition
of the immobilized AFP to its antibody labeled with dual-stabilizer-capped
CdTe NCs, the proposed immunoassay displayed increasing ECL intensity,
leading to a wide calibration range of 10.0 pg/mL to 80.0 ng/mL with
a detection limit of 5.0 pg/mL [signal-to-noise ratio (S/N) = 3] without
coupling any signal amplification procedures. The NIR ECL immunoassay
for real samples displayed very similar results with those of Ru(bpy)<sub>3</sub><sup>2+</sup> reagent kit based commercial ECL immunoassay,
which not only proved for the efficiency of NIR ECL from dual-stabilizer-capped
CdTe NCs but also paved the road for development of novel ECL emitters
and corresponding reagent kits
A Monochromatic Electrochemiluminescence Sensing Strategy for Dopamine with Dual-Stabilizers-Capped CdSe Quantum Dots as Emitters
A promising electrochemiluminescence
(ECL) sensing strategy was
proposed with dual-stabilizers-capped CdSe quantum dots (QDs) as ECL
emitters. The dual-stabilizers-capped CdSe QDs were covalently immobilized
onto p-aminobenzoic acid modified glass carbon electrode with ethylenediamine
as a link molecule. This strategy can preserve the completely passivated
surface states of dual-stabilizers-capped CdSe QDs, so that the sensor
demonstrated eye-visible greenish, band gap engineering and monochromatic
ECL emission at 546 nm with a fwhm of 35 nm. Moreover, the proposed
sensor could accurately quantify dopamine from 10.0 nM to 3.0 μM
with a detection limit of 3.0 nM in practical drug, human urine, and
cerebrospinal fluid samples without any signal amplification techniques.
This strategy is promising for developing ECL sensors with high sensitivity
and spectral selectivity
Molecular-Counting-Free and Electrochemiluminescent Single-Molecule Immunoassay with Dual-Stabilizers-Capped CdSe Nanocrystals as Labels
Biorelated
single-molecule detection (SMD) has been achieved typically
by imaging the redox fluorescent labels and then determining each
label one by one. Herein, we demonstrated that the capping agents
(i.e., mercaptopropionic acid and sodium hexametaphosphate) can facilitate
the electrochemical involved hole (or electron) injecting process
and improve the stability of the dual-stabilizers-capped CdSe nanocrystals
(NCs), so that the CdSe NCs could be electrochemically and repeatedly
inspired to excited states by giving off electrochemiluminescence
(ECL) in a cyclic pattern. With the CdSe NCs as ECL label and carcinoembryonic
antigen (CEA) as target molecule, a convenient single-molecule immunoassay
was proposed by simply detecting the ECL intensity of the dual-stabilizers-capped
CdSe NCs in a sandwich-typed immune complex. The limit of detection
is 0.10 fg/mL at S/N = 3, which corresponds to about 6–8 CEA
molecules in 20 μL of serum sample. Importantly, the ECL spectra
of both CdSe NCs and its conjugate with probe antigen in the immune
complex were almost identical to the photoluminescence spectrum of
bare CdSe NCs, indicating that all emissions were originated from
the same excited species. The molecular-counting-free and ECL-based
SMD might be a promising alternative to the fluorescent SMD
Low-Triggering-Potential Electrochemiluminescence from Surface-Confined CuInS<sub>2</sub>@ZnS Nanocrystals and their Biosensing Applications
Electrochemiluminescence (ECL) of
low triggering potential is strongly
anticipated for ECL assays with less inherent electrochemical interference
and improved long-term stability of the working electrode. Herein,
effects of the thiol capping agents and the states of luminophores,
i.e., the thiol-capped CuInS2@ZnS nanocrystals (CuInS2@ZnS-Thiol), on the ECL triggering potential of CuInS2@ZnS-Thiol/N2H4·H2O
were explored on the Au working electrode. The thiol capping agent
of glutathione (GSH) not only enabled CuInS2@ZnS-Thiol/N2H4·H2O with the stronger oxidative-reduction
ECL than other thiol capping agents but also demonstrated the largest
shift for the ECL triggering potential of CuInS2@ZnS-Thiol/N2H4·H2O upon changing the luminophores
from the monodispersed state to the surface-confined state. CuInS2@ZnS-GSH/N2H4·H2O exhibited
an efficient oxidative-reduction ECL around 0.78 V (vs Ag/AgCl) with
CuInS2@ZnS-GSH of the monodispersed state. Upon employing
CuInS2@ZnS-GSH as the ECL tag and immobilizing them onto
the Au working electrode, the oxidative-reduction ECL of CuInS2@ZnS-GSH/N2H4·H2O was
lowered to 0.32 V (vs Ag/AgCl), which was about 0.88 V lower than
that of traditional Ru(bpy)32+/TPrA (typically
∼1.2 V, vs Ag/AgCl). The ECL of the CuInS2@ZnS-GSH/N2H4·H2O system with the luminophore
of both monodispersed and surface-confined states was spectrally identical
to each other, indicating that this surface-confining strategy exhibited
negligible effect on the excited state for the ECL of CuInS2@ZnS-GSH. A surface-confined ECL sensor around 0.32 V was fabricated
with CuInS2@ZnS-GSH as a luminophore, which could sensitively
and selectively determine the K-RAS gene from 1 to 500 pM with a limit
of detection at 0.5 pmol L–1 (S/N = 3)
Surface-Defect-Involved and Eye-Visible Electrochemiluminescence of Unary Copper Nanoclusters for Immunoassay
A single-stabilizer-capped strategy is proposed for achieving
highly
efficient and surface-defect-involved electrochemiluminescence (ECL)
from unary copper nanoclusters (NCs) via employing l-cysteine
(Cys) as a capping agent of luminophore. The Cys-capped CuNCs (Cys-CuNCs)
can be electrochemically injected with valence band (VB) holes and
exhibit eye-touchable ECL processes around +0.95 and +1.15 V upon
employing TPrA as a coreactant. Both accumulated ECL spectra and spooling
ECL spectra demonstrated that the two ECL processes are of the same
single waveband and spectrally identical to each other with the same
maximum emission wavelength of 640 nm. Promisingly, ECL of the Cys-CuNCs/TPrA
system is obviously red-shifted for ∼150 nm to PL of Cys-CuNCs,
indicating that the bandgap-engineered routes for ECLs of Cys-CuNCs
are completely blocked. The oxidative-reduction ECL process of the
Cys-CuNCs/TPrA system is a kind of highly efficient, eye-visible,
and single-color emission in surface-defect-involved route. The capping
agent of Cys can enable the CuNCs/TPrA system with a stronger ECL
than other thiol capping agents, so that Cys-CuNCs are utilized as
ECL tags for sensitive and selective immunoassays, which exhibit a
wide linear response range from 0.05 pg/mL to 0.5 ng/mL and a limit
of detection of 0.01 pg/mL (S/N = 3) with carcinoembryonic antigen
as the analyte. Moreover, both the luminophore Cys-CuNCs and conjugates
Ab2-CuNCs can be safely stored in aqueous media without
any protector, which is promising for the evolution and clinic application
of metal NC ECL in the surface-defect-involved route
Spectrum-Based Electrochemiluminescent Immunoassay with Ternary CdZnSe Nanocrystals as Labels
Conventional
electrochemiluminescence (ECL) research has been performed
by detecting the total photons (i.e., the ECL intensity). Herein,
systematic spectral exploration on the ECL of dual-stabilizers-capped
ternary CdZnSe nanocrystals (NCs) and its sensing application were
carried out on a homemade ECL spectral acquiring system. The ternary
CdZnSe NCs could be repeatedly injected with electrons via some electrochemical
ways and then result in strong cathodic ECL with the coupling of ammonium
persulfate. ECL spectrum of the CdZnSe NCs was almost identical to
corresponding photoluminescence spectrum, indicating that the excited
states of CdZnSe NCs in ECL were essentially the same as those in
photoluminescence. Importantly, after being labeled to the probe antibody
(Ab<sub>2</sub>) of α-fetal protein (AFP) antigen, the ternary
NCs in the Ab<sub>2</sub>|NCs conjugates could preserve their ECL
spectrum very well. A spectrum-based ECL immunoassay was consequently
proposed with the CdZnSe NCs as ECL tags and AFP as target molecules.
The limit of detection is 0.010 pg/mL, with a signal-to-noise (S/N)
ratio of 3, indicating a sensitive ECL sensing strategy that was different
from the conventional ones. This work might open a pathway to the
spectrally resolved ECL analysis with even-higher S/N ratios than
the fluorescent analysis
